Publikationen (113) Publikationen von ALBERTO VILLAREJO GALENDE

2024

  1. A novel abbreviated version of the Luria neuropsychological diagnosis battery: reliability and convergent validity in Spanish older adults

    Journal of Clinical and Experimental Neuropsychology

2023

  1. Cerebral amyloid angiopathy–related inflammation: clinical features and treatment response in a case series

    Neurologia, Vol. 38, Núm. 8, pp. 550-559

  2. Differences in Striatal Metabolism in [18F]FDG PET in Parkinson’s Disease and Atypical Parkinsonism

    Diagnostics, Vol. 13, Núm. 1

  3. Encefalitis límbica secundaria a neuro-Behçet: una presentación insólita

    Revista de neurologia, Vol. 77, Núm. 2, pp. 61-64

  4. Medical help-seeking intentions among patients with early Alzheimer’s disease

    Frontiers in Psychiatry, Vol. 14

  5. Static first-minute-frame (FMF) PET imaging after 18F-labeled amyloid tracer injection is correlated to [18F]FDG PET in patients with primary progressive aphasia

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 42, Núm. 4, pp. 211-217

2022

  1. Awareness of Diagnosis in Persons with Early-Stage Alzheimer’s Disease: An Observational Study in Spain

    Neurology and Therapy, Vol. 11, Núm. 3, pp. 1183-1192

  2. Hereditary cerebral small vessel disease: Assessment of a HTRA1 variant using protein stability predictors and 3D modelling

    European Journal of Medical Genetics, Vol. 65, Núm. 8

  3. Heterozygous and Homozygous Variants in SORL1 Gene in Alzheimer’s Disease Patients: Clinical, Neuroimaging and Neuropathological Findings

    International Journal of Molecular Sciences, Vol. 23, Núm. 8

  4. Quality of Life and the Experience of Living with Early-Stage Alzheimer's Disease

    Journal of Alzheimer's disease : JAD, Vol. 90, Núm. 2, pp. 719-726

  5. Quejas cognitivas en adultos jóvenes: una aproximación práctica a un motivo creciente de demanda asistencial

    Kranion, Vol. 17, Núm. 4, pp. 128-135

2021

  1. Alteraciones neurológicas

    Fisiopatología de la COVID-19 en diferentes órganos y sistemas (Elsevier), pp. 59-72

  2. Early-Onset Dementia Associated with a Heterozygous, Nonsense, and de novo Variant in the MBD5 Gene

    Journal of Alzheimer's Disease, Vol. 84, Núm. 1, pp. 73-78

  3. Expanding the clinical and genetic spectrum of SQSTM1-related disorders in family with personality disorder and frontotemporal dementia

    Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, Vol. 22, Núm. 7-8, pp. 552-560

  4. First patient with mosaic NOTCH3 gene pathogenic variant. Unrevealed mosaicisms and importance of their detection

    American Journal of Medical Genetics, Part A, Vol. 185, Núm. 2, pp. 591-595

  5. From in-person didactic sessions to videoconferencing during the covid-19 pandemic: Satisfaction survey among participants

    Revista de Neurologia, Vol. 72, Núm. 9, pp. 307-312

  6. High correlation of static first-minute-frame (Fmf) pet imaging after18f-labeled amyloid tracer injection with [18f]fdg pet imaging

    Sensors, Vol. 21, Núm. 15

  7. Increased ykl-40 but not c-reactive protein levels in patients with alzheimer’s disease

    Biomedicines, Vol. 9, Núm. 9

  8. Physical activity and risk of Parkinson's disease and parkinsonism in a prospective population-based study (NEDICES)

    Preventive Medicine Reports, Vol. 23

  9. Report by the Spanish Foundation of the Brain on the social impact of Alzheimer disease and other types of dementia

    Neurologia